Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment

NCT00840034 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00840034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00840034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
January 31, 2010
Enrollment
227 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major